Liu Louisa, Dudheker Neil, Sumarriva Lezama Lhara M, Shah Sameer, Nwaokoro Maureen, Ranpura Vishal
Internal Medicine, University of California, Riverside, Riverside, USA.
Hematology and Oncology, University of California San Diego, San Diego, USA.
Cureus. 2021 Jul 4;13(7):e16168. doi: 10.7759/cureus.16168. eCollection 2021 Jul.
Pure erythroid leukemia (PEL) is an aggressive and exceedingly rare form of acute leukemia characterized as a neoplastic proliferation of immature cells committed to the erythroid lineage. It has a poor overall median survival of two to three months. To our knowledge, there are currently only a handful of reports of PEL arising from polycythemia vera. Most reported cases have been associated with radiation therapy or chemotherapeutic alkylating agents. Here we report a rare occurrence of polycythemia vera treated with phlebotomy and hydroxyurea that underwent leukemic transformation to pure erythroid leukemia.
纯红细胞白血病(PEL)是一种侵袭性极强且极为罕见的急性白血病,其特征为向红细胞系分化的未成熟细胞发生肿瘤性增殖。其总体中位生存期较差,仅为两到三个月。据我们所知,目前仅有少数关于真性红细胞增多症继发纯红细胞白血病的报告。大多数报告的病例与放射治疗或化疗烷化剂有关。在此,我们报告一例罕见的真性红细胞增多症病例,该患者接受了放血和羟基脲治疗,随后发生白血病转化,发展为纯红细胞白血病。